Literature DB >> 17638821

Bilateral symptomatic angle closure associated with a regular dose of citalopram, an SSRI antidepressant.

P Massaoutis, D Goh, P J Foster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17638821      PMCID： PMC1954792          DOI： 10.1136/bjo.2006.107185

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  16 in total

1.  Paroxetine and acute angle-closure glaucoma.

Authors:  H G Bennett; A M Wyllie
Journal:  Eye (Lond)       Date:  1999-10       Impact factor: 3.775

2.  Presumed topiramate-induced bilateral acute angle-closure glaucoma.

Authors:  J T Banta; K Hoffman; D L Budenz; E Ceballos; D S Greenfield
Journal:  Am J Ophthalmol       Date:  2001-07       Impact factor: 5.258

Review 3.  Serotonin and melatonin in the iris/ciliary processes and their involvement in intraocular pressure.

Authors:  N N Osborne
Journal:  Acta Neurobiol Exp (Wars)       Date:  1994       Impact factor: 1.579

4.  Amitriptyline and glaucoma.

Authors:  R F Lowe
Journal:  Med J Aust       Date:  1966-09-10       Impact factor: 7.738

5.  Topiramate-induced bilateral angle-closure glaucoma.

Authors:  Jaime Levy; Ronit Yagev; Alena Petrova; Tova Lifshitz
Journal:  Can J Ophthalmol       Date:  2006-04       Impact factor: 1.882

6.  The presence of serotonin (5-HT1) receptors negatively coupled to adenylate cyclase in rabbit and human iris-ciliary processes.

Authors:  N L Barnett; N N Osborne
Journal:  Exp Eye Res       Date:  1993-08       Impact factor: 3.467

7.  Topiramate-associated acute, bilateral, secondary angle-closure glaucoma.

Authors:  F W Fraunfelder; F T Fraunfelder; Edwin U Keates
Journal:  Ophthalmology       Date:  2004-01       Impact factor: 12.079

8.  Oral imipramine and acute angle closure glaucoma.

Authors:  R Ritch; T Krupin; C Henry; F Kurata
Journal:  Arch Ophthalmol       Date:  1994-01

9.  Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma.

Authors:  Jamie E Craig; Terrence J Ong; Damien L Louis; Jane M Wells
Journal:  Am J Ophthalmol       Date:  2004-01       Impact factor: 5.258

Review 10.  Drug-induced glaucomas: mechanism and management.

Authors:  Ramesh C Tripathi; Brenda J Tripathi; Chris Haggerty
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606
View more
  6 in total

Review 1.  Ocular adverse effects of common psychotropic agents: a review.

Authors:  Sami Richa; Jean-Claude Yazbek
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

2.  Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure.

Authors:  Ciro Costagliola; Francesco Parmeggiani; Francesco Semeraro; Adolfo Sebastiani
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

Review 3.  A review of systemic medications that may modulate the risk of glaucoma.

Authors:  Annie Wu; Anthony P Khawaja; Louis R Pasquale; Joshua D Stein
Journal:  Eye (Lond)       Date:  2019-10-08       Impact factor: 3.775

Review 4.  Psychotropic Drug-Induced Glaucoma: A Practical Guide to Diagnosis and Management.

Authors:  Neeranjali S Jain; Claire W Ruan; Shanil R Dhanji; Richard J Symes
Journal:  CNS Drugs       Date:  2021-02-19       Impact factor: 5.749

5.  Topiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: a case-report.

Authors:  Luca Spaccapelo; Silvia Leschiutta; Claudio Aurea; Anna Ferrari
Journal:  Cases J       Date:  2009-01-26

6.  Long-Term Use of Selective Serotonin Reuptake Inhibitors and Risk of Glaucoma in Depression Patients.

Authors:  Hsin-Yi Chen; Cheng-Li Lin; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.